ESR1 and breast carcinoma: We thus performed retrospective analysis of gene-expression array data using the KMP cohort, which contains a sizeable number of breast cancer patients (1,308 ER-positive, 569 ER-negative, 1,055 luminal, 419 HER2-enriched, and 403 triple-negative/basal-like).